Pharmacological inhibition of TRPM4 hyperpolarizes vascular smooth muscle.
The contractile state of vascular smooth muscle cells is regulated by small changes in membrane potential that gate voltage-dependent calcium channels. The melastatin transient receptor potential (TRP) channel TRPM4 is a critical mediator of pressure-induced membrane depolarization and arterial constriction. A recent study shows that the tricyclic compound 9-phenanthrol inhibits TRPM4, but not the related channel TRPM5. The current study investigated the specificity of 9-phenanthrol and the effects of the compound on pressure-induced smooth muscle depolarization and arterial constriction. Patch-clamp electrophysiology revealed that 9-phenanthrol blocks native TRPM4 currents in freshly isolated smooth muscle cells in a concentration-dependent manner (IC(50) = 10.6 μM). 9-Phenanthrol (30 μM) had no effect on maximum evoked currents in human embryonic kidney cells expressing recombinant TRPC3 or TRPC6 channels. Large-conductance Ca(2+)-activated K(+), voltage-dependent K(+), inwardly rectifying K(+), and voltage-dependent Ca(2+) channel activity in native cerebral artery myocytes was not altered by administration of 9-phenanthrol (30 μM). Using intracellular microelectrodes to record smooth muscle membrane potential in isolated cerebral arteries pressurized to 70 mmHg, we found that 9-phenanthrol (30 μM) reversibly hyperpolarized the membrane from ∼-40 mV to ∼-70 mV. In addition, we found that myogenic tone was reversibly abolished when vessels were exposed to 9-phenanthrol. These data demonstrate that 9-phenanthrol is useful for studying the functional significance of TRPM4 in vascular smooth muscle cells and that TRPM4 is an important regulator of smooth muscle cell membrane depolarization and arterial constriction in response to intraluminal pressure.
Gonzales
Albert L
AL
Vascular Physiology Research Group, Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523, USA.
Garcia
Zarine I
ZI
Amberg
Gregory C
GC
Earley
Scott
S
D000818:Animals; D015220:Calcium Channels / Q000378:metabolism; D002536:Cerebral Arteries / Q000033:anatomy & histology / Q000187:drug effects; D006801:Humans; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D018408:Patch-Clamp Techniques; D010616:Phenanthrenes / Q000494:pharmacology*; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D050053:TRPM Cation Channels / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism*
D015220:Calcium Channels; D010616:Phenanthrenes; D020033:Protein Isoforms; D047428:Protein Kinase Inhibitors; D050053:TRPM Cation Channels; C500239:TRPM4 protein, rat; C091375:9-phenanthrol
Circ Res. 1980 Jul;47(1):1-9
7379260
J Physiol. 2000 Aug 15;527 Pt 1:139-48
10944177
Clin Sci (Lond). 2010 Apr 07;119(1):19-36
20370719
Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H2613-22
17293488
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16586-91
17056714
J Physiol. 1998 Apr 1;508 ( Pt 1):199-209
9490839
Circ Res. 2004 Oct 29;95(9):922-9
15472118
Circ Res. 2005 Dec 9;97(12):1270-9
16269659
Cell. 2002 May 3;109(3):397-407
12015988
Physiol Rev. 1989 Apr;69(2):546-604
2467318
Circ Res. 2002 Feb 22;90(3):248-50
11861411
Br J Pharmacol. 2008 Apr;153(8):1697-705
18297105
Endothelium. 2003;10(1):5-15
12699072
Microcirculation. 2010 May;17(4):237-49
20536737
Am J Physiol Cell Physiol. 2010 Aug;299(2):C279-88
20427713
J Physiol. 1902 May 28;28(3):220-31
16992618
Am J Physiol Heart Circ Physiol. 2005 May;288(5):H2055-61
15604128
Cell Calcium. 2003 Sep;34(3):211-29
12887969
Circ Res. 2001 Feb 16;88(3):325-32
11179201
J Physiol. 2008 Feb 15;586(4):1147-60
18063660
Pflugers Arch. 2008 Mar;455(6):1097-103
17957383
Science. 1995 Oct 27;270(5236):633-7
7570021
Am J Physiol. 1995 Apr;268(4 Pt 1):C799-822
7733230
Stroke. 2007 Aug;38(8):2322-8
17585083